Bionano Genomics (BNGO) Competitors $3.38 -0.08 (-2.31%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$3.37 -0.01 (-0.30%) As of 07/25/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNGO vs. AATC, DAIO, CLIR, MSAI, PRPO, STAI, ASTC, TLIS, AXDX, and SMITShould you be buying Bionano Genomics stock or one of its competitors? The main competitors of Bionano Genomics include Autoscope Technologies (AATC), Data I/O (DAIO), ClearSign Technologies (CLIR), MultiSensor AI (MSAI), Precipio (PRPO), ScanTech AI Systems (STAI), Astrotech (ASTC), Talis Biomedical (TLIS), Accelerate Diagnostics (AXDX), and Schmitt Industries (SMIT). These companies are all part of the "measuring and control equipment" industry. Bionano Genomics vs. Its Competitors Autoscope Technologies Data I/O ClearSign Technologies MultiSensor AI Precipio ScanTech AI Systems Astrotech Talis Biomedical Accelerate Diagnostics Schmitt Industries Autoscope Technologies (NASDAQ:AATC) and Bionano Genomics (NASDAQ:BNGO) are both small-cap measuring and control equipment companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and valuation. Is AATC or BNGO more profitable? Autoscope Technologies has a net margin of 37.59% compared to Bionano Genomics' net margin of -294.05%. Autoscope Technologies' return on equity of 27.06% beat Bionano Genomics' return on equity.Company Net Margins Return on Equity Return on Assets Autoscope Technologies37.59% 27.06% 23.97% Bionano Genomics -294.05%-125.75%-71.96% Do institutionals and insiders believe in AATC or BNGO? 11.4% of Bionano Genomics shares are owned by institutional investors. 21.6% of Autoscope Technologies shares are owned by insiders. Comparatively, 0.9% of Bionano Genomics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts rate AATC or BNGO? Bionano Genomics has a consensus target price of $7.00, indicating a potential upside of 107.10%. Given Bionano Genomics' stronger consensus rating and higher probable upside, analysts clearly believe Bionano Genomics is more favorable than Autoscope Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autoscope Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Bionano Genomics 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Which has higher valuation and earnings, AATC or BNGO? Autoscope Technologies has higher earnings, but lower revenue than Bionano Genomics. Bionano Genomics is trading at a lower price-to-earnings ratio than Autoscope Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAutoscope Technologies$12.89M3.28$6.62M$0.7310.55Bionano Genomics$28.46M0.40-$112.02M-$138.92-0.02 Does the media refer more to AATC or BNGO? In the previous week, Autoscope Technologies and Autoscope Technologies both had 1 articles in the media. Bionano Genomics' average media sentiment score of 1.89 beat Autoscope Technologies' score of 0.00 indicating that Bionano Genomics is being referred to more favorably in the news media. Company Overall Sentiment Autoscope Technologies Neutral Bionano Genomics Very Positive Which has more risk and volatility, AATC or BNGO? Autoscope Technologies has a beta of 0.63, suggesting that its stock price is 37% less volatile than the S&P 500. Comparatively, Bionano Genomics has a beta of 2.2, suggesting that its stock price is 120% more volatile than the S&P 500. SummaryAutoscope Technologies beats Bionano Genomics on 8 of the 15 factors compared between the two stocks. Get Bionano Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for BNGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BNGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNGO vs. The Competition Export to ExcelMetricBionano GenomicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.64M$3.07B$5.70B$9.51BDividend YieldN/A2.37%4.69%4.01%P/E Ratio-0.0221.1828.1020.06Price / Sales0.40285.61429.1688.51Price / CashN/A42.7636.2258.56Price / Book0.198.378.665.87Net Income-$112.02M-$55.19M$3.25B$258.55M7 Day Performance-1.46%5.88%4.22%3.73%1 Month Performance2.74%17.33%10.51%11.75%1 Year Performance-91.02%4.42%34.39%18.02% Bionano Genomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNGOBionano Genomics2.4006 of 5 stars$3.38-2.3%$7.00+107.1%-90.6%$11.64M$28.46M-0.02300Positive NewsAATCAutoscope Technologies1.9203 of 5 stars$7.60+0.1%N/A+14.7%$41.72M$12.89M8.6440DAIOData I/O2.6541 of 5 stars$3.12-0.3%$5.22+67.3%+19.4%$28.83M$21.85M-10.76100News CoverageEarnings ReportAnalyst ForecastGap DownCLIRClearSign Technologies2.3354 of 5 stars$0.53-1.8%$2.00+277.2%-29.9%$27.79M$3.60M-4.4210Positive NewsGap DownMSAIMultiSensor AI3.3371 of 5 stars$0.81+15.4%$2.50+207.2%-44.7%$27.21M$6.30M0.0035Analyst ForecastPRPOPrecipio1.1813 of 5 stars$14.85-4.6%N/A+184.5%$22.45M$20.03M-7.1760Positive NewsSTAIScanTech AI SystemsN/A$0.74+6.9%N/AN/A$18.95M$540K0.00N/APositive NewsEarnings ReportGap UpASTCAstrotech1.7181 of 5 stars$5.76+2.2%N/A-36.2%$9.75M$903K-0.6810Positive NewsTLISTalis BiomedicalN/A$1.25-13.8%N/A-83.7%$2.28M$300K-0.04260AXDXAccelerate DiagnosticsN/AN/AN/AN/A$857K$11.70M-0.01220Gap DownHigh Trading VolumeSMITSchmitt IndustriesN/A$0.02flatN/AN/A$82K$9.89M0.00160 Related Companies and Tools Related Companies AATC Alternatives DAIO Alternatives CLIR Alternatives MSAI Alternatives PRPO Alternatives STAI Alternatives ASTC Alternatives TLIS Alternatives AXDX Alternatives SMIT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BNGO) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionano Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionano Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BNGO Stock Alerts